{"id":1695,"date":"1999-07-01T12:05:00","date_gmt":"1999-07-01T10:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/dauer-der-antikoagulation-nach-idiopathischer-thromboembolie"},"modified":"1999-07-01T12:05:00","modified_gmt":"1999-07-01T10:05:00","slug":"dauer-der-antikoagulation-nach-idiopathischer-thromboembolie","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/dauer-der-antikoagulation-nach-idiopathischer-thromboembolie","title":{"rendered":"Dauer der Antikoagulation nach idiopathischer Thromboembolie"},"content":{"rendered":"<p>Das Research Committee der British Thoracic Society stellte fest, da\u00df nach einer vierw\u00f6chigen Antikoagulation wegen tiefer Beinvenenthrombose, Lungenembolie (oder beiden) mehr Rezidive beobachtet werden als nach einer Antikoagulation f\u00fcr drei Monate (1, 2). Die schwedische Duration of Anticoagulation-Studie (DURAC 1) zeigte, da\u00df nach Antikoagulation f\u00fcr sechs Monate sich weniger Rezidive ereignen als nach Antikoagulation f\u00fcr [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Das Research Committee der British Thoracic Society stellte fest, da\u00df nach einer vierw\u00f6chigen Antikoagulation wegen tiefer Beinvenenthrombose, Lungenembolie (oder beiden) mehr Rezidive beobachtet werden als nach einer Antikoagulation f\u00fcr drei Monate (1, 2). Die schwedische Duration of Anticoagulation-Studie (DURAC 1) zeigte, da\u00df nach Antikoagulation f\u00fcr sechs Monate sich weniger Rezidive ereignen als nach Antikoagulation f\u00fcr [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[137,61,3842,138,54,51,55,136],"class_list":["post-1695","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-antikoagulanzien","tag-beinvenenthrombose","tag-durac-studien","tag-phenprocoumon","tag-thromboembolie","tag-thrombose","tag-venenthrombose","tag-warfarin"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1695"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1695\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}